Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

Saved in:

Bibliographic Details
Published in:	Br J Cancer
Main Authors:	Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas J A, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, Granetto, Cristina, Massuti, Bartomeu, McAdam, Karen, McDermott, Raymond, Martín, Andrés J Muñoz, Papamichael, Demetris, Pazo-Cid, Roberto, Vieitez, Jose M, Zaniboni, Alberto, Carroll, Kevin J, Wagle, Shama, Gaya, Andrew, Mudan, Satvinder S
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2016
Subjects:	Corrigendum
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5117801/ https://ncbi.nlm.nih.gov/pubmed/27727233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.342
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items